Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jiang

Showing results (331-340 of 1,071) with videos related to

Pageof 108
Sort By:
Archives of Drug Information|November 17, 2009
Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese VolunteersMona Darwish, Kenneth Tempero, John G Jiang, et al.
Angiogenesis|June 8, 2006
Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patientsChristian Parr, Chun H Gan, Gareth Watkins, et al.
Molecular Medicine Reports|December 25, 2013
The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (review)Wang Jia, Runchun Lu, Tracey A Martin, et al.
International Journal of Oncology|January 20, 2016
Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitroSioned Owen, Andrew J Sanders, Malcolm D Mason, et al.
Anticancer Research|March 16, 2016
Knockdown of EPHA1 by CRISPR/CAS9 Promotes Adhesion and Motility of HRT18 Colorectal Carcinoma CellsB O Wu, Wen G Jiang, Deshan Zhou, et al.
Biomed Research International|July 28, 2016
Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-AnalysisChengcheng Hao, Zhiyan Wang, Yanan Gu, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 25, 2006
Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancerWen G Jiang, Gareth Watkins, Anthony Douglas-Jones, et al.
Clinical Therapeutics|July 25, 2006
Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteersMona Darwish, Mary Kirby, Philmore Robertson, et al.
Clinical Drug Investigation|August 21, 2007
Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot studyMona Darwish, Mary Kirby, Philmore Robertson, et al.
Oncology Reports|July 16, 2004
The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancerGareth Watkins, Anthony Douglas-Jones, Robert E Mansel, et al.
Pageof 108

Showing results (331-340 of 1,071) with videos related to

Sort By:
Pageof 108
Archives of Drug Information|November 17, 2009
Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese VolunteersMona Darwish, Kenneth Tempero, John G Jiang, et al.
Angiogenesis|June 8, 2006
Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patientsChristian Parr, Chun H Gan, Gareth Watkins, et al.
Molecular Medicine Reports|December 25, 2013
The role of claudin-5 in blood-brain barrier (BBB) and brain metastases (review)Wang Jia, Runchun Lu, Tracey A Martin, et al.
International Journal of Oncology|January 20, 2016
Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitroSioned Owen, Andrew J Sanders, Malcolm D Mason, et al.
Anticancer Research|March 16, 2016
Knockdown of EPHA1 by CRISPR/CAS9 Promotes Adhesion and Motility of HRT18 Colorectal Carcinoma CellsB O Wu, Wen G Jiang, Deshan Zhou, et al.
Biomed Research International|July 28, 2016
Prognostic Value of Osteopontin Splice Variant-c Expression in Breast Cancers: A Meta-AnalysisChengcheng Hao, Zhiyan Wang, Yanan Gu, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 25, 2006
Reduction of isoforms of 15-lipoxygenase (15-LOX)-1 and 15-LOX-2 in human breast cancerWen G Jiang, Gareth Watkins, Anthony Douglas-Jones, et al.
Clinical Therapeutics|July 25, 2006
Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteersMona Darwish, Mary Kirby, Philmore Robertson, et al.
Clinical Drug Investigation|August 21, 2007
Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot studyMona Darwish, Mary Kirby, Philmore Robertson, et al.
Oncology Reports|July 16, 2004
The localisation and reduction of nuclear staining of PPARgamma and PGC-1 in human breast cancerGareth Watkins, Anthony Douglas-Jones, Robert E Mansel, et al.
Pageof 108